{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:41:03Z","timestamp":1761864063656,"version":"build-2065373602"},"reference-count":53,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T00:00:00Z","timestamp":1572912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>A paradigm shift in plastic and reconstructive surgery is brought about the usage of cell-based therapies for wound healing and regeneration. Considering the imitations in the reconstructive surgeries in restoring tissue loss and deficiency, stem cell-based therapy, in particular, has been expected to pave the way for a new solution to the regenerative approaches. Limitations in the reconstructive surgeries in restoring tissue loss and deficiency have paved the way for new regenerative approaches. Among them, adipose-derived stem\/progenitor cells (ADSCs)-based therapy could be the most promising clue, since ADSCs have pluripotent differentiation capabilities not only in adipocytes but also in a variety of cell types. Accumulating evidences have indicated that the unfavorable development of adipose-tissue damage, namely, lipodystrophy, is a systemic complication, which is closely related to metabolic abnormality. Considering ADSC-based regenerative medicine should be applied for the treatment of lipodystrophy, it is inevitable to ascertain whether the ADSCs obtained from the patients with lipodystrophy are capable of being used. It will be very promising and realistic if this concept is applied to lipoatrophy; one form of lipodystrophies that deteriorates the patients\u2019 quality of life because of excessive loss of soft tissue in the exposed areas such as face and extremities. Since lipodystrophy is frequently observed in the human immunodeficiency virus (HIV)-infected patients receiving highly active antiretroviral therapy (HAART), the present study aims to examine the biological potentials of ADSCs isolated from the HIV-infected patients with lipodystrophy associated with the HAART treatment. Growth properties, adipogenic differentiation, and mitochondrial reactive oxygen species (ROS) production were examined in ADSCs from HIV-infected and HIV-uninfected patients. Our results clearly demonstrated that ADSCs from both patients showed indistinguishable growth properties and potentials for adipocyte differentiation in vitro. Thus, although the number of cases were limited, ADSCs isolated from the patients with lipodystrophy retain sufficient physiological and biological activity for the reconstitution of adipose-tissue, suggesting that ADSCs from the patients with lipodystrophy could be used for autologous ADSC-based regenerative therapy.<\/jats:p>","DOI":"10.3390\/ijms20215505","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T06:47:57Z","timestamp":1572936477000},"page":"5505","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Biological Features Implies Potential Use of Autologous Adipose-Derived Stem\/Progenitor Cells in Wound Repair and Regenerations for the Patients with Lipodystrophy"],"prefix":"10.3390","volume":"20","author":[{"given":"Keiji","family":"Suzuki","sequence":"first","affiliation":[{"name":"Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8225-9363","authenticated-orcid":false,"given":"Sadanori","family":"Akita","sequence":"additional","affiliation":[{"name":"Department of Plastic Surgery, Wound Repair and Regeneration, Fukuoka University, School of Medicine, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan"},{"name":"Department of Plastic and Reconstructive Surgery, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Ohtsuru","sequence":"additional","affiliation":[{"name":"Department of Radiation Health Management, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima 960-1295, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Plastic and Reconstructive Surgery, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunichi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Radiation Medical Sciences, Atomic Bomb Disease Institute, Nagasaki University, 1-12-4 Sakamoto, Nagasaki 852-8523, Japan"},{"name":"Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima 960-1295, Japan"},{"name":"Center for Advanced Radiation Emergency Medicine at the National Institutes for Quantum and Radiological Science and Technology, 4-9-1 Anagawa, Inage-ku, Chiba 263-8555, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,11,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: Implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2015.00002","article-title":"Induced pluripotent stem cells: Applications in regenerative medicine, disease modeling, and drug discovery","volume":"3","author":"Singh","year":"2015","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/s41556-019-0344-z","article-title":"Advances in stem cell research and therapeutic development","volume":"21","author":"Aiuti","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.stem.2009.10.014","article-title":"Fighting fat with fat: The expanding field of adipose stem cells","volume":"5","author":"Zeve","year":"2009","journal-title":"Cell Stem Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1091\/mbc.e09-07-0589","article-title":"The adipose-derived stem cell: Looking back and looking ahead","volume":"21","author":"Zuk","year":"2010","journal-title":"Mol. Biol. Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/iwj.12569","article-title":"The regenerative role of adipose-derived stem cells (ADSC) in plastic and reconstructive surgery","volume":"14","author":"Naderi","year":"2017","journal-title":"Int. Wound J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4252\/wjsc.v9.i8.107","article-title":"Adipose-derived stromal cell in regenerative medicine: A review","volume":"9","author":"Tabatabaei","year":"2017","journal-title":"World J. Stem Cells"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/jcp.24965","article-title":"In vitro evaluation of different methods of handling human liposuction aspirate and their effect on adipocytes and adipose derived stem cells","volume":"230","author":"Palumbo","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Chu, D.T., Nguyen Thi Phuong, T., Tien, N.L.B., Tran, D.T., Minh, L.B., Thanh, V.V., Gia Anh, P., Pham, V.H., and Thi Nga, V. (2019). Adipose tissue stem cells for therapy: An update on the progress of isolation, culture, storage, and clinical application. J. Clin. Med., 8.","DOI":"10.3390\/jcm8070917"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2302\/kjm.54.132","article-title":"Multipotential differentiation of adipose tissue-derived stem cells","volume":"54","author":"Strem","year":"2005","journal-title":"Keio J. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"812693","DOI":"10.1155\/2012\/812693","article-title":"Adipose-derived mesenchymal stromal\/stem cells: Tissue localization, characterization, and heterogeniety","volume":"2012","author":"Baer","year":"2012","journal-title":"Stem Cells Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/HP.0b013e3181d3d52c","article-title":"Mesenchymal stem cell therapy for cutaneous radiation syndrome","volume":"98","author":"Akita","year":"2010","journal-title":"Health Phys."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","article-title":"Lipodystrophy: Pathophysiology and advances in treatment","volume":"7","author":"Fiorenza","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.10.002","article-title":"The development of antiretroviral therapy and its impact on the HIV\/AIDS pandemic","volume":"85","author":"Broder","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.antiviral.2009.10.007","article-title":"Current status and challenges of antiretroviral research and therapy","volume":"85","author":"Cihlar","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/01.aids.0000327510.68503.e8","article-title":"HIV epidemiology and the effects of antiviral therapy on long-term consequences","volume":"22","author":"Quinn","year":"2008","journal-title":"AIDS"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrendo.2011.151","article-title":"Management of the metabolic effects of HIV and HIV drugs","volume":"8","author":"Brown","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1468-1293.2001.00071.x","article-title":"HIV-associated lipodystrophy","volume":"2","author":"Mallon","year":"2001","journal-title":"HIV Med."},{"key":"ref_20","first-page":"3","article-title":"Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy","volume":"9","author":"Mallon","year":"2007","journal-title":"AIDS Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5501\/wjv.v4.i2.56","article-title":"Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs","volume":"4","author":"Maselli","year":"2015","journal-title":"World J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5501\/wjv.v6.i3.49","article-title":"Additional attention to combination antiretroviral therapy-related lipodystrophy","volume":"6","author":"Kobayashi","year":"2017","journal-title":"World J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ecl.2016.06.012","article-title":"Lipodystrophy syndromes","volume":"45","author":"Hussain","year":"2016","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(99)06102-4","article-title":"Mitochondrial toxicity induced by nucleotide-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy","volume":"354","author":"Brinkman","year":"1999","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.molmed.2010.03.002","article-title":"HIV-associated lipodystrophy: From fat injury to premature aging","volume":"16","author":"Lagathu","year":"2010","journal-title":"Trends Mol. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1742-1241.2007.01385.x","article-title":"Long-term complications of antiretroviral therapy: Lipoatrophy","volume":"61","author":"Waters","year":"2007","journal-title":"Int. J. Clin. Pract."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12985-015-0298-0","article-title":"HIV infection and antiretroviral therapy lead to unfolded protein response activation","volume":"12","author":"Borsa","year":"2015","journal-title":"Virol. J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(98)03391-1","article-title":"Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance","volume":"351","author":"Carr","year":"1998","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/313854","article-title":"HIV protease inhibitor-related lipodystrophy syndrome","volume":"30","author":"Carr","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1097\/00002030-200005050-00023","article-title":"Protease inhibitor therapy-associated lipodystrophy, hypertriglyceridaemia and diabetes mellitus","volume":"14","author":"Paparizos","year":"2000","journal-title":"AIDS"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: A prospective cohort study","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archderm.141.10.1220","article-title":"Evaluation of Coleman lipostructure for treatment of facial lipoatrophy in patients with human immunodeficiency virus and parameters associated with the efficiency of this technique","volume":"141","author":"Burnouf","year":"2005","journal-title":"Arch. Dermatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1468-1293.2008.00682.x","article-title":"Correction of facial lipoatrophy using autologous fat transplants in HIV-infected adolescents","volume":"10","author":"Dollfus","year":"2009","journal-title":"HIV Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAD.0b013e32833f1463","article-title":"Surgical correction of HIV-associated facial lipoatrophy","volume":"25","author":"Guaraldi","year":"2011","journal-title":"AIDS"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/QAD.0b013e3283423219","article-title":"Mitochondrial damage in adipose tissue of untreated HIV-infected patients","volume":"25","author":"Garrabou","year":"2011","journal-title":"AIDS"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"532704","DOI":"10.4061\/2010\/532704","article-title":"Noncultured autologous adipose-derived stem cells therapy for chronic radiation injury","volume":"2010","author":"Akita","year":"2010","journal-title":"Stem Cells Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ymeth.2008.03.006","article-title":"Adipose-derived stem cells: Isolation, expansion, and differentiation","volume":"45","author":"Bunnell","year":"2008","journal-title":"Methods"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.3494308","article-title":"Extended culture of mouse embryo cells without senescence: Inhibition by serum","volume":"236","author":"Loo","year":"1987","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Gentile, P. (2019). Autologous cellular method using micrografts of human adipose tissue derived follicle stem cells in androgenic alopecia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143446"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/PRS.0b013e31824ecae6","article-title":"Human adipose stem cells: Current clinical applications","volume":"129","author":"Gir","year":"2012","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/MOT.0000000000000694","article-title":"Adipogenesis for soft tissue reconstitution","volume":"24","author":"Karagoz","year":"2019","journal-title":"Curr. Opin. Organ Transplant."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/dgd.12049","article-title":"Adipose-derived mesenchymal stem cells and regenerative medicine","volume":"55","author":"Konno","year":"2013","journal-title":"Dev. Growth Differ."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mazini, L., Rochette, L., Amine, M., and Malka, G. (2019). Regenerative capacity of adipose derived stem cells (SDSCs), comparison with mesenchymal stem cells (MSCs). Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20102523"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/stem.1076","article-title":"Concise review: Adipose-derived stem cells as a novel tool for future regenerative medicine","volume":"30","author":"Mizuno","year":"2012","journal-title":"Stem Cells"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Trivisonno, A., Alexander, R.W., Baldari, S., Cohen, S.R., Di Rocco, G., Gentile, P., Magalon, G., Magalon, J., Miller, R.B., and Womack, H. (2019). Concise review: Intraoperative strategies for minimal manipulation of autologous adipose tissue for cell- and tissue-based therapies. Stem Cells Transl. Med.","DOI":"10.1002\/sctm.19-0166"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1517\/14712598.2013.823153","article-title":"Adipose tissue-derived stem cells in clinical applications","volume":"13","author":"Pikula","year":"2013","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2217\/rme.11.119","article-title":"Human adipose-derived cells: A update on the transition to clinical translation","volume":"7","author":"Gimble","year":"2012","journal-title":"Regen. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/j.biochi.2013.07.015","article-title":"Proteomic techniques for characterization of mesenchymal stem cell secretome","volume":"95","author":"Skalnikova","year":"2013","journal-title":"Biochimie"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1524-475X.2009.00499.x","article-title":"Hypoxia-enhanced wound-healing function of adipose-derived stem cells: Increase in stem cell proliferation and up-regulation of VEGF and bFGF","volume":"17","author":"Lee","year":"2009","journal-title":"Wound Repair Regen."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Lombardi, F., Palumbo, P., Augello, F.R., Cifone, M.G., Cinque, B., and Giuliani, M. (2019). Secretome of adipose tissue-derived stem cells (ASCs) as a novel trend in chronic non-healing wounds: An overview of experimental in vitro and in vivo studies and methodological variables. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20153721"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13287-019-1152-x","article-title":"Microvesicles from human adipose stem cells promote wound healing by optimizing cellular functions via AKT and ERK signaling pathways","volume":"10","author":"Ren","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13287-017-0483-8","article-title":"Systematic review of patient factors affecting adipose stem cell viability and function: Implications for regenerative therapy","volume":"8","author":"Varghese","year":"2017","journal-title":"Stem Cell Res. Ther."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/21\/5505\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:31:56Z","timestamp":1760189516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/21\/5505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,5]]},"references-count":53,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2019,11]]}},"alternative-id":["ijms20215505"],"URL":"https:\/\/doi.org\/10.3390\/ijms20215505","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2019,11,5]]}}}